What You Should Know:
– ONWARD Medical N.V. (Euronext: ONWD), a leading medical technology company specializing in innovative spinal cord stimulation therapies, announced the signing of a loan agreement of up to €52.5M ($56.6M) with Runway Growth Capital LLC, a U.S.-based lender.
– This strategic partnership will provide vital funding for the company’s continued growth and advancement of life-changing SCS therapies for people with spinal cord injury (SCI).
– ONWARD Medical is a medical technology company dedicated to creating innovative SCS therapies for people with SCI. Their ARC™ (Autonomic Restoration Control) System utilizes SCS to target specific neural pathways, aiming to restore function and improve quality of life for patients.
